FDA adds strongest warning to Sarepta gene therapy
The FDA mandates a 'black box' warning for Sarepta's Elevidys gene therapy, linked to two patient deaths. Learn about the new safety restrictions and what this means for treatment.
The FDA mandates a 'black box' warning for Sarepta's Elevidys gene therapy, linked to two patient deaths. Learn about the new safety restrictions and what this means for treatment.
Two brothers in Chicago face a devastating insurance denial for a groundbreaking gene therapy treatment, highlighting a critical gap in US healthcare coverage for rare diseases.
Subscribe to our newsletter to receive the latest updates in your inbox!
We hate spammers and never send spam